Literature DB >> 23453644

A closer look at the effects of postoperative radiotherapy by stage and nodal status: updated results of an individual participant data meta-analysis in non-small-cell lung cancer.

Sarah Burdett, Larysa Rydzewska, Jayne F Tierney, David J Fisher.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23453644     DOI： 10.1016/j.lungcan.2013.02.005

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  16 in total

Review 1.  Radiotherapy for single station N2 NSCLC.

Authors:  Jan P van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2014-08

2.  Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC).

Authors:  Fumihiro Tanaka; Kazue Yoneda
Journal:  Surg Today       Date:  2015-04-30       Impact factor: 2.549

3.  Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.

Authors:  John L Mikell; Theresa W Gillespie; William A Hall; Dana C Nickleach; Yuan Liu; Joseph Lipscomb; Suresh S Ramalingam; Raj S Rajpara; Seth D Force; Felix G Fernandez; Taofeek K Owonikoko; Rathi N Pillai; Fadlo R Khuri; Walter J Curran; Kristin A Higgins
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

Review 4.  Postoperative radiotherapy for non-small cell lung cancer.

Authors:  Sarah Burdett; Larysa Rydzewska; Jayne Tierney; David Fisher; Mahesh Kb Parmar; Rodrigo Arriagada; Jean Pierre Pignon; Cecile Le Pechoux
Journal:  Cochrane Database Syst Rev       Date:  2016-10-11

5.  Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?

Authors:  Matthew J Bott; Aalok P Patel; Vivek Verma; Traves D Crabtree; Daniel Morgensztern; Clifford G Robinson; Graham A Colditz; Saiama Waqar; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Stephen Broderick; Bryan F Meyers; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2016-03-12       Impact factor: 5.209

6.  Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach.

Authors:  Lucyna Kepka; Joanna Socha; Monika Rucinska; Ewa Wasilewska-Tesluk; Katarzyna Komosinska
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

7.  Predicting prognosis of post-chemotherapy patients with resected IIIA non-small cell lung cancer.

Authors:  Difan Zheng; Yiyang Wang; Yuan Li; Yihua Sun; Haiquan Chen
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

8.  The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.

Authors:  Wen Feng; Qin Zhang; Xiao-Long Fu; Xu-Wei Cai; Zheng-Fei Zhu; Huan-Jun Yang; Jia-Qing Xiang; Ya-Wei Zhang; Hai-Quan Chen
Journal:  BMC Cancer       Date:  2015-05-02       Impact factor: 4.430

9.  Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer?

Authors:  Amit A Kulkarni; Abdul Rafeh Naqash; Sonam Puri; Rodrigo Dienstmann
Journal:  JCO Precis Oncol       Date:  2021-02-17

10.  Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer.

Authors:  Shih-Min Lin; Hsiu-Ying Ku; Che-Yu Hsu; Chih-Liang Wang; Gee-Chen Chang; Cheng-Shyong Chang; Tsang-Wu Liu
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.